Actively Recruiting

Phase Not Applicable
Age: 18Years - 70Years
All Genders
NCT06027749

Impact of Capturing Ictal Events With Ultra-long-term Ambulatory EEG Monitoring With Remote EEG Monitoring System.

Led by Epitel, Inc. · Updated on 2024-08-27

65

Participants Needed

2

Research Sites

85 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The goal of this clinical trial is to test Epitel's™ Remote EEG Monitoring System's (REMI™) ability to record electroencephalography (EEG) of seizure events in an ambulatory setting for extended periods (14 - 28 days) in patients presenting with questionable seizure characterization. The main questions it aims to answer are: • Can more seizure events be recorded in fourteen (14) days than can be recorded in three (3) days? • Do treating clinicians find clinical value in extended fourteen (14) - twenty-eight (28) days of EEG? Participants will wear a portable EEG device (REMI) for fourteen (14) to twenty-eight (28) days in their home/community setting.

CONDITIONS

Official Title

Impact of Capturing Ictal Events With Ultra-long-term Ambulatory EEG Monitoring With Remote EEG Monitoring System.

Who Can Participate

Age: 18Years - 70Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients have a reported history of seizures (epileptic, non-epileptic, or unknown)
  • Have a minimum reported seizure rate of one every two weeks
  • Are prescribed an ambulatory EEG study as part of routine care
  • Is Male or Female between the ages of 18 and 70
  • Can understand and sign written informed consent, or have a legal guardian provide consent
  • The Patient (or Primary Caregiver) must be competent to follow all study procedures
  • The Patient must be willing to use the System for a prolonged period (up to 30 days), for a minimum of 20 hours/day
Not Eligible

You will not qualify if you...

  • Is sensitive or allergic to medical acrylics, silicones, or hydrogels
  • Is enrolled in another investigational drug or device trial
  • Is homeless or in a home without a power supply
  • Cannot read, speak, or understand English (and does not have a translator)

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

University of South Florida

Tampa, Florida, United States, 33606

Actively Recruiting

2

Medical University of South Carolina

Charleston, South Carolina, United States, 29407

Enrolling by Invitation

Loading map...

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

DIAGNOSTIC

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here